Objectives: The aims of this study were to clarify the influence of cardiac diastolic and peripheral vascular function on the exercise capacity of patients with coronary bypass surgery (CABG) and diabetes mellitus (DM) by tissue Doppler imaging (TDI) and flow-mediated vasodilatation (FMD), and to investigate interrelations between exercise capacity and LV diastolic function, endothelial function and biochemical parameters. Methods: We analyzed the exercise capacity, TDI at the mitral annulus and FMD in 51 uncomplicated first-time CABG survivors (23 DM) at an average interval of 21.6 ± 12.2 months after surgery. Results: Diabetics had lower E’, A’, VO2peak, (a-v)O2 difference, and higher E/E’ ratios (p < 0.05) than non-DM patients, but not FMD (p = 0.17). The A and E/E’ ratios correlated negatively with VO2peak after age adjustment (r = –0.336, p = 0.024). In addition, HbA1c, and triglyceride also correlated negatively with VO2peak (r = –0.377, –0.307, respectively, p < 0.05). Conclusions: Diabetics after CABG had more advanced diastolic dysfunction and oxygen extraction impairment than non-DM. It suggests these factors could contribute to lower exercise capacity, risk of developing heart failure despite preserved systolic function and poorer long-term survival of diabetic patients after CABG.

1.
Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997;96:1761–1769.
2.
Hirotani T, Kameda T, Kumamoto T, et al: Effects of coronary artery bypass grafting using internal thoracic arteries for diabetic patients. J Am Coll Cardiol 1999;34:532–538.
3.
Choi JS, Cho RK, Kim KB, et al: Does diabetes affect the postoperative outcomes after total arterial off-pump coronary bypass surgery in multivessel disease? Ann Thorac Surg 2005;80:1353–1361.
4.
Vanhees L, Fagard R, Thijs L, Staessen J, Amery A: Prognostic significance of peak exercise capacity in patients with coronary artery disease. J Am Coll Cardiol 1994;23:358–363.
5.
Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE: Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002;346:793–801.
6.
Kavanagh T, Mertens DJ, Hamm LF, et al: Prediction of long-term prognosis in 12,169 men referred for cardiac rehabilitation. Circulation 2002;106:666–671.
7.
Weiner DA, Ryan TJ, Parsons L, et al: Long-term prognostic value of exercise testing in men and women from the Coronary Artery Surgery Study (CASS) registry. Am J Cardiol 1995;75:865–870.
8.
Kavanagh T, Mertens DJ, Hamm LF, et al: Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol 2003;42:2139–2143.
9.
Vanoverschelde JJ, Essanri B, Vanbutsele R, et al: Contribution of left ventricular diastolic function to exercise capacity in normal subjects. J Appl Physiol 1993;74:2225–2233.
10.
Okura H, Inoue H, Tomon M, et al: Impact of Doppler-derived left ventricular diastolic performance on exercise capacity in normal individuals. Am Heart J 2000;139:716–722.
11.
Gharavi AG, Diamond JA, Goldman AY, et al: Resting diastolic function and left ventricular mass are related to exercise capacity in hypertensive men but not in women. Am J Hypertens 1998;11:1252–1257.
12.
Kim HK, Kim YJ, Cho YS, et al: Determinants of exercise capacity in hypertensive patients: new insights from tissue Doppler echocardiography. Am J Hypertens 2003;16:564–569.
13.
Takahashi N, Iwasaka T, Sugiura T, et al: Left ventricular dysfunction during dynamic exercise in noninsulin-dependent diabetic patients with retinopathy. Cardiology 1991;78:23–30.
14.
Nicoline A, Longobardi G, Furgi G, et al: Left ventricular diastolic filling in diabetes mellitus with and without hypertension. Am J Hypertens 1995;8:382–389.
15.
Skaluba SJ, Litwin SE: Mechanism of exercise intolerance: insight from tissue Doppler imaging. Circulation 2004;109:972–977.
16.
Kuvin JT, Patel AR, Sliney KA, et al: Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol 2001;38:1843–1849.
17.
Linke A, Schoene N, Gielen S, et al: Endothelial dysfunction in patient with chronic heart failure: systemic effects of lower limb exercise training. J Am Coll Cardiol 2001;37:392–397.
18.
Clarkson P, Montgomery HE, Mullen MJ, et al: Exercise training enhances endothelial function in young men. J Am Coll Cardiol 1999;33:1379–1385.
19.
Lavrencic A, Salobir BG, Keber I: Physical training improves flow-mediated dilatation in patients with the polymetabolic syndrome. Arterioscler Thromb Vasc Biol 2000;20:551–555.
20.
Watt K, Beye P, Siafarikas A, et al: Exercise training normalizes vascular dysfunction and improves central adiposity in obese adolescents. J Am Coll Cardiol 2004;43:1823–1827.
21.
Hambrecht R, Wolf A, Gielen S, et al: Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 2000;342:454–460.
22.
Hambrecht R, Adams V, Erbs S, et al: Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation endothelial nitric oxide synthase. Circulation 2003;107:3152–3158.
23.
Hambrecht R, Fiehn E, Weigl C, et al: Regular physical exercise corrects endothelial function and improves exercise capacity in patients with chronic heart failure. Circulation 1998;98:2709–2715.
24.
Oh JK, Seward JB, Tajik J: The Echo Manual, ed 2. Philadelphia, Lippincott Williams & Wilkins, 1999, pp 7–43.
25.
De Boeck BW, Cramer MM, Oh JK, van der Aa RP, Jaarsma W: Spectral pulsed tissue Doppler imaging in diastole: a tool to increase our insight in and assessment of diastolic relaxation of the left ventricle. Am Heart J 2003;146:411–419.
26.
Chao CL, Kuo TL, Lee TY, et al: Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults. Circulation 2000;101:485–490.
27.
Strauer BE, Motz W, Vogt M, Schwartzkopff B: Impaired coronary flow reserve in NIDDM: a possible role for diabetic cardiopathy in humans. Diabetes 1997;46(suppl 2):S119–S124.
28.
Cosson S, Kevorkian JP: Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy. Diabetes Metab 2003;29:455–466.
29.
Harrison MR, Clifton GD, Pennell AT, DeMaria AN: Effect of heart rate on left ventricular diastolic transmitral flow velocity patterns assessed by Doppler echocardiography in normal subjects. Am J Cardiol 1991;67:622–627.
30.
Ceilk SK, Sagcan A, Buket S, Yuksel M, Kultursay H: Effect of coronary artery bypass surgery on diastolic and systolic parameters of left ventricle in type II diabetic patients. J Diabetes Complications 2003;17:73–77.
31.
Genovesi-Ebert A, Marabotti C, Palombo C, Giaconi S, Rossi G, Ghione S: Echo Doppler diastolic function and exercise tolerance. Int J Cardiol 1994;43:67–73.
32.
Ommen SR, Nishimura RA, Appleton CP, et al: Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressure: a comparative simultaneous Doppler-catheterization study. Circulation 2000;102:1788–1794.
33.
Regensteiner JG, Sippel J, McFarling ET, Wolfel EE, Hiatt WR: Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc 1995;27:875–881.
34.
Baldi JC, Aoina JL, Oxenham HC, Bagg W, Doughty RN: Reduced exercise arteriovenous O2 difference in type 2 diabetes. J Appl Physiol 2003;94:1033–1038.
35.
Simoneau JA, Kelley DE: Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 1997;83:166–171.
36.
Blaak EE, van Aggel-Leijssen DP, Wagenmakers AJ, Saris WH, van Baak MA: Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 2000;49:2102–2107.
37.
Borlaug BA, Melenovsky V, Russell SD, et al: Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006;114:2138–2147.
38.
Prior JP, Quiñones MJ, Hernandez-Pampaloni M, et al: Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 2005;111:2291–2298.
39.
Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA: Impaired nitric oxide-mediated vasodilation in patients with non-insulin dependent diabetes mellitus. J Am Coll Cardiol 1996;27:567–574.
40.
Goldman MD: Lung dysfunction in diabetes. Diabetes Care 2003;26:1915–1918.
41.
Weynand B, Jonckheere A, Frans A, Rahier J: Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respiration 1999;66:14–19.
42.
Liang P, Virginia H, Fukagawa NK: Increased prevalence of mitochondrial DNA deletions in skeletal muscle of older individuals with impaired glucose tolerance: possible marker of glycemic stress. Diabetes 1997;46:920–923.
43.
Demir I, Ermis C, Altunbas H, Balci MK: Serum HbA1c levels and exercise capacity in diabetes patients. Jpn Heart J 2001;42:607–616.
44.
Wong CY, O’Moore-Sullivan T, Fang ZY, et al: Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome. Am J Cardiol 2005;96:1686–1691.
45.
Van de Veire NR, De Winter O, Philippe J, et al: Maximal oxygen uptake at peak exercise in elderly patients with coronary artery disease and preserved left ventricular function: the role of inflammation on top of tissue Doppler-derived systolic and diastolic function. Am Heart J 2006;152:297.e1–e7.
46.
Wong CY, Byrne NM, O’Moore-Sullivan T, et al: Effect of weight loss due to life intervention on subclinical cardiovascular dysfunction in obesity (body mass index >30kg/m2). Am J Cardiol 206;98:1593–1598.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.